PerkinElmer is the parent company of PerkinElmer Genetics, USA's leading provider of newborn screening services. PerkinElmer Genetics pioneered the use of Tandem Mass Spectrometry in Newborn Screening, one of the biggest advances in making Newborn Screening affordable. PerkinElmer Genetics has screened over 4 Million babies and continues to screen over 400, 000 babies every year. NeoGen Labs has replicated PerkinElmer Genetics' Tandem Mass Spectrometry lab in the US, in India.

Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 6,500 employees and serves more than 85,000 research and industry customers worldwide through its global network of operations.

Bio-Rad’s Clinical Diagnostic Division provides the Newborn Screening kits and equipment for NeoGen’s biochemical testing (CH, CAH, G6PD, GALT, CF and BIOT)

LabIndia Instruments Pvt. Ltd. was founded in 1981 and promoted by a group of committed and visionary technocrats, engineers and professionals. The founders have since grown LabIndia into a highly successful sales, marketing, service and support organization that is recognized all over India as a key supplier of state-of-the-art instrumentation and reagents for biotechnology and life science research.

LabIndia supports our Applied Biosystems Tandem Mass Spectrometry Platform for Newborn Screening.

Whatman began in 1740 with a small, country-based English mill making fine, handcrafted paper. Today, Whatman is a part of GE Healthcare and is a global leader in separations technology.. The company provides filter papers, membranes and sophisticated consumables for applications in the analytical, health care, and bioscience markets.

Whatman is the sole manufactures of the special 903 filter paper that is used all over the world to collect blood samples for newborn screening. For NeoGen Labs, Whatman created a unique 903 filter paper design that is used to collect blood samples for NeoGen’s 1st Step Newborn Screening Test. The bar coded filter paper and the adjoining form is manufactured in FDA approved facilities, quality checked by CDC and meets all CLSI standards for collection of dried blood spots for newborn screening.